Case Study
Learn how expert IND publishing supported an Understaffed Regulatory team.
download
Learn how Veristat has supported some of our Biotech Sponsors in advancing their RNA therapeutics.
Successful Engagement with FDA to Achieve SPA Approval for Running the Phase III Pivotal Trial
Using intratumor RECIST (itRECIST) criteria to measure effectiveness of cancer therapeutics
Regulatory Submission Strategy and Novel Efficacy Endpoint for Treatment of an Ultra-Rare and ...
Veristat was brought in to create and manage a full development program for a gene therapy for a ...
A mid-size pharmaceutical company and its development partner, a small biotechnology company ...
A clinical-stage biopharmaceutical company came to Veristat with a complex statistical methodology ...
A client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in ...
